Chunjiang Wang

1.6k total citations
100 papers, 1.1k citations indexed

About

Chunjiang Wang is a scholar working on Epidemiology, Oncology and Pharmacology. According to data from OpenAlex, Chunjiang Wang has authored 100 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Chunjiang Wang's work include Cancer Immunotherapy and Biomarkers (13 papers), Autoimmune Bullous Skin Diseases (9 papers) and Drug-Induced Adverse Reactions (9 papers). Chunjiang Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Autoimmune Bullous Skin Diseases (9 papers) and Drug-Induced Adverse Reactions (9 papers). Chunjiang Wang collaborates with scholars based in China, United States and Taiwan. Chunjiang Wang's co-authors include Weijin Fang, Shikun Liu, Yang He, Wei Sun, Tie Liu, Jicheng He, Xiangdong Peng, Yulu Zhou, Zuojun Li and Ao Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Chemical Geology.

In The Last Decade

Chunjiang Wang

92 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunjiang Wang China 18 217 182 133 118 85 100 1.1k
Liuping Zhang China 20 327 1.5× 103 0.6× 56 0.4× 123 1.0× 38 0.4× 81 1.2k
R. P. Tripathi India 21 549 2.5× 100 0.5× 95 0.7× 28 0.2× 106 1.2× 76 1.7k
Weijie Sun China 21 519 2.4× 138 0.8× 116 0.9× 12 0.1× 125 1.5× 115 1.7k
Arnaud Hubert France 22 104 0.5× 59 0.3× 114 0.9× 65 0.6× 146 1.7× 80 1.6k
Ming Yin China 22 270 1.2× 129 0.7× 69 0.5× 47 0.4× 145 1.7× 51 1.3k
Qinghua Shang China 20 241 1.1× 279 1.5× 17 0.1× 75 0.6× 29 0.3× 74 1.9k
Hyung Rae Kim South Korea 20 287 1.3× 124 0.7× 126 0.9× 259 2.2× 80 0.9× 76 1.4k
Masataka Kato Japan 26 193 0.9× 404 2.2× 67 0.5× 33 0.3× 135 1.6× 172 2.3k
Sang Wook Kim South Korea 23 398 1.8× 168 0.9× 22 0.2× 22 0.2× 202 2.4× 97 1.5k
Guangming Zhou China 21 488 2.2× 46 0.3× 656 4.9× 46 0.4× 101 1.2× 91 1.9k

Countries citing papers authored by Chunjiang Wang

Since Specialization
Citations

This map shows the geographic impact of Chunjiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunjiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunjiang Wang more than expected).

Fields of papers citing papers by Chunjiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunjiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunjiang Wang. The network helps show where Chunjiang Wang may publish in the future.

Co-authorship network of co-authors of Chunjiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunjiang Wang. A scholar is included among the top collaborators of Chunjiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunjiang Wang. Chunjiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunjiang, et al.. (2025). Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease. European journal of medical research. 30(1). 37–37.
2.
Sun, Wei, et al.. (2024). Clinical Characteristics, Treatment, and Prognosis of Amoxicillin‐Induced AGEP/ALEP. Dermatologic Therapy. 2024(1). 2 indexed citations
3.
Li, Zuojun, et al.. (2024). Clinical Features, Diagnosis, Treatment, and Prognosis of Heparin‐Induced Bullous Hemorrhagic Dermatosis. Dermatologic Therapy. 2024(1). 1 indexed citations
4.
Zhao, Shaoli, et al.. (2024). Clinical features, treatment, and outcomes of nivolumab induced psoriasis. Investigational New Drugs. 43(1). 42–49. 17 indexed citations
5.
Wang, Chunjiang, Hanqing Zeng, Weijin Fang, & Liying Song. (2023). Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis. Investigational New Drugs. 41(2). 333–339. 7 indexed citations
6.
Wu, Tian, et al.. (2023). Clinical Manifestations and Management of Terbinafine‐Induced Acute Generalized Exanthematous Pustulosis. Dermatologic Therapy. 2023(1). 2 indexed citations
7.
Deng, Zhenzhen, et al.. (2023). IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis. Frontiers in Pharmacology. 14. 1124628–1124628. 46 indexed citations
8.
Liu, Miao, et al.. (2023). Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid. Investigational New Drugs. 41(6). 802–807. 4 indexed citations
9.
Deng, Hongyi, et al.. (2022). Clinical features, diagnosis and management of cephalosporin‐induced acute generalized exanthematous pustulosis. Journal of Clinical Pharmacy and Therapeutics. 47(12). 2008–2013. 4 indexed citations
10.
Wang, Chunjiang, et al.. (2022). Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome. Frontiers in Pharmacology. 13. 998239–998239. 2 indexed citations
11.
Wang, Chunjiang, et al.. (2022). Analysis of Clinical Features of Non-steroidal Anti-inflammatory Drugs Induced Kounis Syndrome. Frontiers in Cardiovascular Medicine. 9. 901522–901522. 5 indexed citations
12.
Wang, Chunjiang, Hongyi Deng, Yunfei Xu, & Ying Liu. (2022). Literature review of the clinical characteristics of metformin-induced hepatotoxicity. Frontiers in Pharmacology. 13. 969505–969505. 7 indexed citations
13.
Wang, Chunjiang, et al.. (2021). Retrospective analysis of skin photosensitivity induced by pirfenidone. Journal of Clinical Pharmacy and Therapeutics. 47(2). 194–199. 2 indexed citations
14.
Wang, Chunxia, et al.. (2021). A Pilot Study of Nutritional Status Prior to Bariatric Surgery in South China. Frontiers in Nutrition. 8. 697695–697695. 3 indexed citations
15.
Su, Yanhong, et al.. (2021). Analysis of the clinical characteristics of dabigatran-induced oesophagitis. European Journal of Hospital Pharmacy. 30(e1). e24–e28. 2 indexed citations
16.
Wang, Chunjiang, et al.. (2020). Clinical characteristics of insulin autoimmune syndrome caused by methimazole in Chinese population. Zhongguo linchuang yaolixue yu zhiliaoxue. 25(2). 209. 1 indexed citations
17.
Zuo, Shanru, Xiao‐cong Zuo, Yang He, et al.. (2017). Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. Journal of Cancer. 9(2). 321–330. 36 indexed citations
18.
Deng, Zhenzhen, Chunjiang Wang, Zuojun Li, Bing Li, & Shikun Liu. (2013). Peginterferon alpha versus other antiviral regimes for Chinese HBeAg-positive chronic hepatitis B patients.. PubMed. 38(12). 1193–207. 1 indexed citations
19.
Li, Zuojun, Yonghua Hu, Bin Li, et al.. (2012). A Highly Sensitive Fluorescent Probe for HClO and Its Application in Live Cell Imaging. Journal of Fluorescence. 22(5). 1201–1207. 16 indexed citations
20.
Wang, Chunjiang, et al.. (2010). Establishment and dynamic histopathology observation of rats model with endometritis. Journal of Northwest A&F University. 38(4). 1–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026